The effects of angiotensin receptor-neprilysin inhibitors on clinical outcomes in heart failure with mildly reduced or preserved ejection fraction: real-world evidence from the CCA Database-HF Center
Event: ESC Congress 2024
Topic: Pharmacotherapy
Session: Heart failure: drug therapy and multidisciplinary care
Ablation for atrial fibrillation improves the outcomes in patients with heart failure with preserved ejection fraction: a single-center cohort study
Event: ESC Congress 2023
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session: Heart failure with preserved ejection fraction: bedside
